Summary:
- The article discusses a study published in the journal Nature that investigates the relationship between mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma.
- The study found that the presence of mosaic chromosomal alterations in hematopoietic cells was associated with shorter progression-free survival and overall survival in multiple myeloma patients.
- The findings suggest that the assessment of mosaic chromosomal alterations in hematopoietic cells could be a useful tool for predicting prognosis and guiding treatment decisions in multiple myeloma patients.